Filing Details

Accession Number:
0001415889-23-016642
Form Type:
4
Zero Holdings:
No
Publication Time:
2023-12-18 17:36:27
Reporting Period:
2023-12-14
Accepted Time:
2023-12-18 17:36:27
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1800 Abbott Laboratories ABT Pharmaceutical Preparations (2834) 360698440
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1778070 F Andrea Wainer 100 Abbott Park Road
Abbott Park IL 60064
Executive Vice President No No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Shares Without Par Value Acquisiton 2023-12-14 15,000 $44.40 80,027 No 4 M Direct
Common Shares Without Par Value Disposition 2023-12-14 15,000 $108.00 65,027 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Shares Option (right to buy) Disposition 2023-12-14 15,000 $0.00 15,000 $44.40
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
38,271 2020-02-17 2027-02-16 No 4 M Direct
Footnotes
  1. Employee stock option granted pursuant to the Abbott Laboratories 2017 Incentive Stock Program, in a transaction exempt from Section 16 under Rule 16b-3.